Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera®
Clinical trial NCT03061838 · TERMINATED
Trial details
- NCT number
- NCT03061838
- Sponsor
- Biointegrator LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-27
- Primary completion
- 2018-03-14
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.